Radioiodine-resistant thyroid cancer
Radioiodine-resistant (RAI-R) thyroid cancer, also known as radioiodine-refractory differentiated thyroid cancer (RAI-R DTC), occurs when thyroid cancer cells are unable to effectively uptake and utilize radioactive iodine in treatment. This resistance can lead to disease progression and potentially a poorer prognosis. RAI-R DTC is more common in older patients, those with advanced disease, and those with distant metastases.
